JNJ

Johnson & Johnson

269.99

Sep 18 • 3:59 PM ET -0.23 (-0.09%)

270.20

Aftermarket • 7:53 PM ET +0.21 (0.08%)

Healthcare Drug Manufacturers - General USA Mega NYSE

Peers: LLY MRK PFE ABBV BMY AZN NVS AMGN SNY NVO

| Held by: VTI VOO IVV SPY VTV XLV VIG VYM VHT SPYM

Index	DJIA, S&P 500
Market Cap	650.65B
Enterprise Value	678.93B
Income	21.04B
Sales	97.94B
Book/sh	35.28
Cash/sh	8.61
Dividend Est.	5.38 (1.99%)
Dividend TTM	5.28 (1.96%)
Dividend Ex-Date	Aug 25, 2026
Dividend Gr. 3/5Y	4.92% 5.25%
Payout	46.59%
Employees	140800
IPO	Sep 25, 1944

P/E	31.29
Forward P/E	21.24
PEG	2.16
P/S	6.64
P/B	7.65
P/C	31.34
P/FCF	29.25
EV/EBITDA	19.86
EV/Sales	6.93
Quick Ratio	0.81
Current Ratio	1.09
Debt/Eq	0.58
LT Debt/Eq	0.44
Option/Short	Yes / Yes

EPS (ttm)	8.63
EPS next Y	12.71
EPS next Q	2.85
EPS this Y	6.85%
EPS next Y	10.26%
EPS next 5Y	9.84%
EPS past 3/5Y	17.88% 14.90%
Sales past 3/5Y	5.56% 2.67%
EPS Y/Y TTM	-7.21%
Sales Y/Y TTM	8.07%
EPS Q/Q	-0.92%
Sales Q/Q	6.64%
Earnings	Oct 13 BMO
EPS/Sales Surpr.	1.59% 0.99%

Insider Own	0.13%
Insider Trans	-7.92%
Inst Own	77.49%
Inst Trans	0.11%
ROA	10.67%
ROE	25.74%
ROIC	17.20%
Gross Margin	68.03%
Oper. Margin	26.99%
Profit Margin	21.48%
SMA20	0.08%
SMA50	2.55%
SMA200	13.13%
Trades

Shs Outstand	2.41B
Shs Float	2.41B
Short Float	0.90%
Short Ratio	2.88
Short Interest	21.67M
52W High	281.07 -3.94%
52W Low	173.33 55.77%
Volatility	1.73% 1.76%
ATR (14)	5.25
RSI (14)	54.63
Beta	0.20
Rel Volume	2.18
Avg Volume	7.53M
Volume	16,428,397

Perf Week	1.66%
Perf Month	-1.25%
Perf Quarter	18.21%
Perf Half Y	13.63%
Perf YTD	30.46%
Perf Year	55.02%
Perf 3Y	66.18%
Perf 5Y	63.88%
Perf 10Y	128.32%
Recom	1.89
Target Price	282.10
Prev Close	270.22
Price	269.99
Change %	-0.09%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-02-26	Resumed	UBS	Buy	$320
May-13-26	Upgrade	Leerink Partners	Market Perform → Outperform	$265
Apr-08-26	Resumed	TD Cowen	Buy	$250
Jan-28-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$262
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$230
Oct-20-25	Upgrade	Daiwa Securities	Neutral → Outperform	$203
Oct-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$212
Sep-23-25	Upgrade	Guggenheim	Neutral → Buy	$206
Jul-23-25	Upgrade	Erste Group	Hold → Buy
May-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$153
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185

Show Previous Ratings

Sep-18-26 05:23PM	What Would It Take For Eli Lilly Stock To Keep Climbing? (Trefis)
04:14PM	Is Johnson & Johnson Stock Expensive, Or Is STELARA Hiding The Real Price? (Trefis)
02:09PM	Merck Stock Nearly Doubled Without A Change In Its Revenue Growth (Trefis)
08:33AM	Can Intuitive Surgical Make Up For A Lower Price Per Surgery? (Trefis)
Sep-17-26 03:17PM	Can Volume Keep Covering Eli Lilly's Price Cuts? (Trefis)
03:06PM	Loading…
03:06PM	Is ISRG Stock Really As Expensive As It Looks? (Trefis)
12:31PM	Why BSX Stock Lost More Than Half Its Value While Sales Kept Rising (Trefis)
08:11AM	What Happens To AbbVie Stock If SKYRIZI Slows Down? (Trefis)
Sep-16-26 04:12PM	Is Pfizer's New Business Big Enough To Carry The Old One? (Trefis)
03:29PM	J&J Slips as Caplyta Clears a Quality-of-Life Test (GuruFocus.com)
03:12PM	Should You Judge JNJ Stock Without STELARA? (Trefis)
03:10PM	These ETFs Could Thrive in a Market Overcome by Interest-Rate Worries (Barrons.com)
02:33PM	ALVO Stock Jumps On Double Upgrade Why Barclays Sees A 59% Upside (Stocktwits)
12:24PM	Why This Biotech Stock Just Got a Rare Double Upgrade (Barrons.com)
06:58AM	J&J sells Laminar LAA closure assets it bought 3 years ago (MedTech Dive)
08:44PM	Loading…
Sep-15-26 08:44PM	Merck Stock: Is The $70 Billion Pipeline Worth the Premium? (Trefis)
07:40PM	LEGNs New CEO From Novartis Paves Way For Buyout Speculation (Stocktwits)
03:00PM	Has BSX Stock Finally Hit Bottom? (Trefis)
12:08AM	AI Safety Fears Drive Investors to J&J, Costco, and CrowdStrike for Cybersecurity (BeInCrypto)
12:00AM	SLS, IBRX, IOVA In Focus Amid Big Pharmas Early Cancer-Asset Hunt: J&J Flags M&A Sweet Spot, Pfizer Eyes Phase 1-2 Deals (Stocktwits)
Sep-14-26 11:00PM	RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) plus LAZCLUZE (lazertinib) with prophylactic strategies shows low rates of treatment-related events at WCLC 2026 (PR Newswire)
05:32PM	CTNM Stock Slumps 10% After-Hours Whats The JNJ Connection? (Stocktwits)
04:09PM	Is This LLY Stock Dip Big Enough To Be Worth Buying? (Trefis)
03:57PM	Why Is Pfizer Stock Paying You So Much To Wait? (Trefis)
12:42PM	Apollo rumoured to be eyeing $20bn takeover of J&Js orthopaedics business (Medical Device Network)
10:34AM	Get Paid To Wait For ISRG Stock To Go On Sale (Trefis)
09:53AM	J&J in talks to sell DePuy Synthes to Apollo for $20 billion (Quartz)
09:31AM	Johnson & Johnson Shares Rise on Reported Apollo Talks for Orthopedics Unit (InvestorsHub)
Sep-13-26 09:45PM	Johnson & Johnson's RYBREVANT (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer (PR Newswire)
Sep-11-26 07:47PM	JNJ Stock Edges Up After-Hours On Apollos $20B Orthopedics Talks (Stocktwits)
06:26PM	Loading…
06:26PM	Apollo Global Is Said in Talks to Acquire J&Js Orthopedics Unit (Bloomberg)
03:11PM	Is AbbVie Stock Actually Overpriced? (Trefis)
02:50PM	Is This BSX Stock Pullback Worth The Patience? (Trefis)
11:15AM	3 Top Dividend Aristocrats To Own Near All-Time Highs (Zacks)
Sep-10-26 03:10PM	Merck Stock Vs. LLY: Why Is The Slower Grower More Expensive? (Trefis)
02:24PM	Barron's Got Cooper Wrong but the Contact-Lens Stock Now Looks Cheap (Barrons.com)
01:57PM	JNJ Stock: Is the Rally Running Out of Steam? (Trefis)
01:05PM	Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? (Trefis)
11:05AM	Why Has AbbVie Gone Quiet About Humira? (Trefis)
07:45AM	Johnson & Johnson Receives CE Marking for ACUVUE OASYS MAX Reusable Contact Lenses (Business Wire)
06:30AM	2 Reasons Cooper Companies Stock Is By Far the Worst in the S&P 500 Today (Barrons.com)
Sep-09-26 10:32PM	Amgen's Forward Multiple Looks Cheap Until You Price The Margins It Assumes (Trefis)
04:41PM	What Eli Lilly Was Telling You While It Rationed Its Own Launches (Trefis)
04:22PM	How Much Can ISRG Stock Still Move Against You? (Trefis)
02:06PM	BSX Stock: Is It Time To Buy Or Sell Puts? (Trefis)
11:46AM	Tyra disappoints investors with bladder cancer data (BioPharma Dive)
10:44AM	Tyra Biosciences Stock Plunges 22% as Bladder Cancer Pill Fails to Impress (Barrons.com)
Sep-08-26 01:39PM	Exclusive: J&J Snack Foods CEO sees a leaner business set up to return to growth (Investing.com)
01:08PM	Is AbbVie Stock Too Reliant On Skyrizi? (Trefis)
10:36AM	What Merck Stopped Saying About GARDASIL Should Change What You Watch (Trefis)
08:00AM	Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026 (PR Newswire)
Sep-04-26 02:25PM	How Much Upside Can BSX Stock's Growth Deliver? (Trefis)
12:57PM	Was JNJ Stock Rally Actually Its Own? (Trefis)
08:00AM	Trailing rivals, AbbVie scores win with dual-acting myeloma drug (BioPharma Dive)
Sep-03-26 05:26PM	J&J Gains as AbbVie Posts 74% Myeloma Response (GuruFocus.com)
04:17PM	Protolabs CEO sees big impact from US reshoring despite potential tariffs (Yahoo Finance Video)
12:07PM	Is Merck Stock Pricing In A Post-Keytruda Future Too Soon? (Trefis)
11:54AM	ABBV Stock Has Returned $62 Billion To Shareholders. Should You Care? (Trefis)
11:24AM	Is Johnson & Johnson Stock Priced For More Growth Than It Has Guided? (Trefis)
10:41AM	AbbVie could take BiTE of Tecvayli market share on Phase III MM win (Clinical Trials Arena)
Sep-02-26 04:55PM	Amgen Stock Signals Its Confidence. The Market Agrees. (Trefis)
04:21PM	Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit (Business Wire)
03:37PM	ISRG Stock: The Best House On The Block Costs The Most (Trefis)
02:19PM	Can AI Save Pfizer Stock Before Its Patent Cliff Hits? (Trefis)
01:52PM	The Wide Divide Priced Into Boston Scientific Stock (Trefis)
01:16PM	How Did Merck Stock Beat The Market With Slowing Sales? (Trefis)
12:42PM	J&J Jumps as UBS Lifts Its Target to $320 (GuruFocus.com)
09:45AM	Johnson & Johnson, Boeing share gains contribute to Dow's 250-point climb (MarketWatch)
06:00AM	Enovis inks eCential takeover to develop surgical ortho robots (MedTech Dive)
Sep-01-26 05:08AM	The hidden scale-out problem behind CAR-Ts growth (Pharma Voice)
Aug-31-26 08:47PM	The Peer-Group Mispricing Sitting On BSX Stock (Trefis)
06:08PM	Chris Benecchi Named Inventivas New Chief Operating Officer (Exec Edge)
05:08PM	Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results (Business Wire)
Aug-28-26 03:09PM	Did A Product Swap Fuel JNJ Stocks 54% Surge? (Trefis)
02:35PM	Can Merck Stock Outrun Its Pipeline? (Trefis)
01:22PM	J&J's China Pill Win Challenges Its Own Injection Franchise (GuruFocus.com)
Aug-27-26 08:19PM	Amgen Stock Signals Its Confidence. The Market Agrees. (Trefis)
08:12PM	Can ISRG Stock Defend Its $131B Valuation? (Trefis)
01:01PM	Is Merck Stock Reaching A Valuation Ceiling At 6x Sales? (Trefis)
12:29PM	Has BSX Stock Fallen Far Enough To Buy? (Trefis)
10:25AM	Can Cost Cuts And 2030 Targets Really Save Pfizer Stock? (Trefis)
Aug-26-26 06:21PM	Top Analyst Reports for JPMorgan, Johnson & Johnson & Mastercard (Zacks)
03:51PM	Time To Squeeze 14% Yield Out Of Battered BSX Stock? (Trefis)
03:41PM	Has AbbVie Stock Become Too Expensive to Buy? (Trefis)
03:31PM	How Much Upside Is Left in JNJ Stock? (Trefis)
02:54PM	J&J's First Anemia Approval Meets a $652 Billion Reality (GuruFocus.com)
09:33AM	Can Eli Lilly Stock Keep Surging As Drug Prices Fall? (Trefis)
06:11AM	Zepbound may cut healthcare costs, study says; Summit, Akeso drug hits in another China trial (BioPharma Dive)
Aug-25-26 01:58PM	Eli Lilly Found a New Gear. You Paid For It. (Trefis)
01:21PM	J&J's First-In-Disease Approval Barely Moves a $666 Billion Stock (GuruFocus.com)
12:38PM	J&Js Imaavy secures expanded US approval in rare blood disorder (Pharmaceutical Technology)
12:05PM	The Floor Under BSX Stock Is Being Tested Again (Trefis)
11:08AM	The Hospital Bet That Reframes The Intuitive Surgical Stock Story (Trefis)
05:57AM	Solvonis CEO: 'Strong tailwinds' for CNS as £1.3m fuels drug pipeline (Proactive)
Aug-24-26 07:35PM	Eli Lilly Stock Raised Its Forecast, So Why Is The Market Shrugging? (Trefis)
07:12PM	FDA approves IMAAVY (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients (PR Newswire)
05:03PM	Q2 Earnings Season Winds Down: 3 Companies That Broke Records (Zacks)
03:18PM	Johnson & Johnson Rises 1.3% as Investors Seek Stability (GuruFocus.com)
Aug-21-26 02:40PM	Lilly's Multiple Assumes Less Growth Than You Think (Trefis)
02:01PM	Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening (Trefis)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

CEO & ChairmanMr. Joaquin Duato

Executive VP & CFOMr. Joseph James Wolk CPA

Ph.D.Dr. John C. Reed M.D.

Executive VP & Worldwide Chairman of MedTechMr. Timothy Schmid

Controller & Chief Accounting OfficerMr. Robert J. Decker Jr.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schmid Timothy	EVP, WW Chair, MedTech	Sep 02 '26	Option Exercise	144.99	33,597	4,871,389	47,974	Sep 04 09:08 AM
Schmid Timothy	EVP, WW Chair, MedTech	Sep 02 '26	Sale	274.74	33,597	9,230,440	25,447	Sep 04 09:08 AM
Schmid Timothy	Officer	Sep 02 '26	Proposed Sale	274.74	33,597	9,230,440		Sep 02 11:26 AM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Aug 17 '26	Option Exercise	115.67	15,000	1,735,050	209,451	Aug 18 06:31 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Aug 17 '26	Sale	263.36	15,000	3,950,400	194,451	Aug 18 06:31 PM
Taubert Jennifer L	Officer	Aug 17 '26	Proposed Sale	263.36	15,000	3,950,418		Aug 17 12:51 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 13 '26	Option Exercise	115.67	123,291	14,261,070	399,258	Aug 14 04:35 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 13 '26	Sale	261.17	123,291	32,199,927	275,967	Aug 14 04:35 PM
Duato Joaquin	Officer	Aug 13 '26	Proposed Sale	261.17	123,291	32,199,927		Aug 13 02:12 PM
Duato Joaquin	CEO and Chairman of the Board	Aug 05 '26	Sale	258.15	48,480	12,515,010	275,967	Aug 07 05:50 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Aug 06 '26	Option Exercise	131.94	9,344	1,232,847	32,912	Aug 07 05:44 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Aug 06 '26	Sale	257.00	15,918	4,090,960	16,994	Aug 07 05:44 PM
Forminard Elizabeth	Officer	Aug 06 '26	Proposed Sale	257.00	15,918	4,090,957		Aug 06 02:02 PM
Joaquin Duato	CEO, Chariman	Aug 05 '26	Proposed Sale	254.93	48,480	12,359,006		Aug 05 06:07 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 20 '26	Option Exercise	130.77	23,054	3,014,701	46,057	Jul 21 05:27 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 20 '26	Sale	251.27	23,054	5,792,686	23,003	Jul 21 05:27 PM
Broadhurst Vanessa	Officer	Jul 20 '26	Proposed Sale	251.27	23,054	5,792,689		Jul 20 01:35 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Jun 11 '26	Option Exercise	115.67	10,000	1,156,700	124,288	Jun 12 05:23 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Jun 11 '26	Sale	241.15	10,000	2,411,500	114,288	Jun 12 05:23 PM
Wengel Kathryn E	Officer	Jun 11 '26	Proposed Sale	240.15	10,000	2,401,539		Jun 11 01:44 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '26	Option Exercise	0.00	25,255	0	35,913	May 04 04:58 PM
Decker Robert J	VP Corporate Controller	Feb 27 '26	Option Exercise	115.67	4,075	471,355	27,757	Mar 03 04:21 PM
Decker Robert J	VP Corporate Controller	Feb 27 '26	Sale	247.87	4,075	1,010,070	23,682	Mar 03 04:21 PM
Decker Robert J	Officer	Feb 27 '26	Proposed Sale	247.87	4,075	1,010,070		Feb 27 02:35 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 20 '26	Sale	245.66	1,322	324,763	25,447	Feb 23 05:20 PM
Schmid Timothy	Officer	Feb 20 '26	Proposed Sale	245.66	1,322	324,763		Feb 20 10:46 AM
Swanson James D.	EVP, CIO	Feb 13 '26	Option Exercise	132.73	51,418	6,824,543	47,211	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 17 '26	Option Exercise	164.62	20,521	3,378,167	46,219	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 15 '26	Option Exercise	0.00	1,201	0	26,007	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 13 '26	Sale	243.73	41,559	10,129,312	25,020	Feb 18 09:12 PM
Swanson James D.	EVP, CIO	Feb 17 '26	Sale	242.70	20,521	4,980,447	25,698	Feb 18 09:12 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '26	Option Exercise	0.00	1,241	0	114,613	Feb 18 09:12 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '26	Option Exercise	0.00	14,357	0	120,096	Feb 18 09:12 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '26	Option Exercise	0.00	994	0	20,081	Feb 18 09:12 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '26	Option Exercise	0.00	4,012	0	20,286	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 17 '26	Option Exercise	126.65	64,693	8,193,223	72,347	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '26	Option Exercise	0.00	3,849	0	39,778	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '26	Option Exercise	0.00	39,242	0	51,463	Feb 18 09:12 PM
Wolk Joseph J	Exec VP, CFO	Feb 17 '26	Sale	242.80	89,654	21,767,827	14,000	Feb 18 09:12 PM
Decker Robert J	VP Corporate Controller	Feb 15 '26	Option Exercise	0.00	683	0	23,777	Feb 18 09:12 PM
Decker Robert J	VP Corporate Controller	Feb 13 '26	Option Exercise	0.00	3,053	0	23,950	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 17 '26	Option Exercise	156.89	51,648	8,103,281	42,868	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '26	Option Exercise	0.00	3,196	0	13,469	Feb 18 09:12 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 17 '26	Sale	243.00	53,931	13,105,233	10,658	Feb 18 09:12 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 15 '26	Option Exercise	0.00	2,024	0	24,112	Feb 18 09:11 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 13 '26	Option Exercise	0.00	14,357	0	29,591	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '26	Option Exercise	0.00	3,441	0	195,396	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '26	Option Exercise	0.00	28,714	0	206,318	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '26	Option Exercise	121.17	22,623	2,741,335	40,394	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '26	Option Exercise	0.00	2,054	0	27,217	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '26	Option Exercise	0.00	4,877	0	26,994	Feb 18 09:11 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '26	Sale	244.33	22,623	5,527,506	26,769	Feb 18 09:11 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '26	Option Exercise	0.00	8,187	0	326,407	Feb 18 09:11 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '26	Option Exercise	0.00	76,523	0	351,501	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '26	Option Exercise	0.00	1,018	0	29,470	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '26	Option Exercise	0.00	9,002	0	32,452	Feb 18 09:11 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 17 '26	Sale	243.39	6,197	1,508,288	23,003	Feb 18 09:11 PM
Schmid Timothy	Officer	Feb 18 '26	Proposed Sale	244.33	22,623	5,527,546		Feb 18 11:14 AM
Broadhurst Vanessa	Officer	Feb 17 '26	Proposed Sale	243.39	6,197	1,508,300		Feb 17 04:10 PM
Swanson James D.	Officer	Feb 17 '26	Proposed Sale	242.70	20,521	4,980,510		Feb 17 02:52 PM
Wolk Joseph J	Officer	Feb 17 '26	Proposed Sale	242.80	89,654	21,767,965		Feb 17 02:43 PM
REED JOHN C	Officer	Feb 17 '26	Proposed Sale	243.00	53,931	13,105,233		Feb 17 12:44 PM
Swanson James D.	Officer	Feb 13 '26	Proposed Sale	243.73	41,559	10,129,246		Feb 13 02:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 06 '26	Option Exercise	101.87	15,571	1,586,218	32,460	Feb 10 09:46 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 06 '26	Option Exercise	101.87	5,625	573,019	19,744	Feb 09 07:42 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 06 '26	Option Exercise	101.87	38,945	3,967,327	133,226	Feb 09 07:40 PM
Forminard Elizabeth	EVP, Chief Legal Officer	Feb 05 '26	Option Exercise	129.51	8,921	1,155,359	21,774	Feb 06 05:46 PM
Forminard Elizabeth	Officer	Feb 05 '26	Proposed Sale	237.90	6,226	1,481,195		Feb 05 04:31 PM
Duato Joaquin	CEO and Chairman of the Board	Jan 26 '26	Sale	221.23	100,000	22,122,893	30,852	Jan 28 06:07 PM
Joaquin Duato	CEO, Chariman	Jan 26 '26	Proposed Sale	220.14	100,000	22,014,000		Jan 26 04:57 PM
MORIKIS JOHN G	Director	Nov 26 '25	Buy	206.15	1,250	257,688	1,849	Dec 01 04:15 PM
JOHNSON & JOHNSON	10% Owner	Nov 26 '25	Sale	10.03	6,337	63,560	4,040,861	Dec 01 04:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 24 '25	Sale	10.06	2,200	22,132	4,047,198	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 21 '25	Sale	10.00	500	5,000	4,049,398	Nov 25 12:54 PM
JOHNSON & JOHNSON	10% Owner	Nov 12 '25	Sale	10.00	1,000	10,000	4,049,898	Nov 14 03:07 PM
JOHNSON & JOHNSON	10% Owner	Nov 06 '25	Sale	10.21	52,332	534,310	4,051,098	Nov 10 03:28 PM
JOHNSON & JOHNSON	10% Owner	Nov 07 '25	Sale	10.00	200	2,000	4,050,898	Nov 10 03:28 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Option Exercise	157.92	21,721	3,430,180	32,379	Oct 20 07:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Oct 17 '25	Sale	192.71	21,721	4,185,793	10,658	Oct 20 07:13 PM
REED JOHN C	Officer	Oct 17 '25	Proposed Sale	192.71	21,721	4,185,794		Oct 17 10:23 AM

Open in Screener

PRU

Prudential Financial Inc

118.40

Sep 18 • 3:59 PM ET +0.47 (0.40%)

118.40

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Financial Insurance - Life USA Large NYSE

PRU Prudential Financial Inc daily Stock Chart

Peers: MET AFL MFC SLF LNC UNM AIG EQH VOYA TRV

| Held by: VTI VOO VO IVV DVY SPY VTV XLF VOE RSP

Index	S&P 500
Market Cap	40.85B
Enterprise Value	-
Income	3.87B
Sales	64.77B
Book/sh	91.47
Cash/sh	-
Dividend Est.	5.60 (4.73%)
Dividend TTM	5.55 (4.69%)
Dividend Ex-Date	Aug 25, 2026
Dividend Gr. 3/5Y	4.00% 4.18%
Payout	54.03%
Employees	36824
IPO	Dec 13, 2001

P/E	10.72
Forward P/E	7.96
PEG	2.03
P/S	0.63
P/B	1.29
P/C	-
P/FCF	3.72
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	2.28
Debt/Eq	1.10
LT Debt/Eq	0.75
Option/Short	Yes / Yes

EPS (ttm)	11.04
EPS next Y	14.88
EPS next Q	3.46
EPS this Y	-0.28%
EPS next Y	3.42%
EPS next 5Y	3.92%
EPS past 3/5Y	- -
Sales past 3/5Y	2.23% 1.28%
EPS Y/Y TTM	144.26%
Sales Y/Y TTM	9.38%
EPS Q/Q	88.24%
Sales Q/Q	14.10%
Earnings	Aug 04 AMC
EPS/Sales Surpr.	15.97% -1.65%

Insider Own	0.21%
Insider Trans	4.94%
Inst Own	65.65%
Inst Trans	0.29%
ROA	0.51%
ROE	12.61%
ROIC	7.09%
Gross Margin	-
Oper. Margin	7.58%
Profit Margin	5.98%
SMA20	-0.96%
SMA50	-1.57%
SMA200	9.09%
Trades

Shs Outstand	345.21M
Shs Float	344.28M
Short Float	3.93%
Short Ratio	7.64
Short Interest	13.55M
52W High	127.72 -7.30%
52W Low	91.89 28.85%
Volatility	1.83% 1.95%
ATR (14)	2.47
RSI (14)	46.44
Beta	0.83
Rel Volume	1.78
Avg Volume	1.77M
Volume	3,154,856

Perf Week	-0.70%
Perf Month	-3.13%
Perf Quarter	11.14%
Perf Half Y	27.99%
Perf YTD	4.89%
Perf Year	13.99%
Perf 3Y	19.70%
Perf 5Y	14.80%
Perf 10Y	49.08%
Recom	3.43
Target Price	113.50
Prev Close	117.93
Price	118.40
Change %	0.40%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-09-26	Downgrade	Argus	Buy → Hold
May-04-26	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$92
Apr-22-26	Downgrade	Jefferies	Buy → Hold	$98
Apr-22-26	Downgrade	Barclays	Equal Weight → Underweight	$91
Feb-25-26	Downgrade	Wells Fargo	Equal Weight → Underweight	$103
Dec-16-25	Initiated	Mizuho	Neutral
Sep-16-25	Initiated	Wolfe Research	Peer Perform
Jan-23-25	Initiated	BMO Capital Markets	Underperform	$101
Nov-14-24	Upgrade	Evercore ISI	Underperform → In-line	$117 → $140
Oct-09-24	Initiated	TD Cowen	Hold	$130
Sep-05-24	Initiated	Barclays	Equal Weight	$118
Aug-12-24	Upgrade	Wells Fargo	Underweight → Equal Weight	$113
May-22-24	Upgrade	Jefferies	Hold → Buy	$121 → $143
Feb-09-24	Downgrade	Raymond James	Strong Buy → Mkt Perform
Jan-03-24	Downgrade	JP Morgan	Overweight → Neutral	$119 → $118
Oct-05-23	Initiated	Deutsche Bank	Hold	$99
Sep-14-23	Upgrade	Jefferies	Underperform → Hold	$70 → $93
Aug-24-23	Upgrade	Raymond James	Mkt Perform → Strong Buy	$125
Apr-04-23	Upgrade	JP Morgan	Neutral → Overweight	$114
Jan-09-23	Downgrade	Goldman	Neutral → Sell	$98 → $96

Show Previous Ratings

Sep-18-26 09:00AM	Prudential Financial Announces Sale of Its Stake in Alexforbes (Business Wire)
Sep-03-26 06:00AM	Prudential Advisors Welcomes Zachary Karason to Mid America Financial Group (PR Newswire)
Aug-31-26 04:18PM	PGIM Closed-End Funds Declare Distributions for September, October, and November 2026 (Business Wire)
Aug-24-26 09:00AM	Employees Want Workplace Benefits Built for Real Life, Not One-Size-Fits-All Programs (Business Wire)
Aug-21-26 08:18AM	Prudential Financial, Inc. to Participate in 2026 Barclays Global Financial Services Conference; Live Webcast Available (Business Wire)
04:54PM	Loading…
Aug-20-26 04:54PM	Private Credit's Next Big Thing Is $1 Trillion in British Pensions (The Wall Street Journal)
Aug-17-26 09:00AM	Prudential Introduces Protection IUL, Expanding Its Indexed Universal Life Lineup With More Flexible Options for Today's Customers (Business Wire)
Aug-13-26 08:18AM	Prudential Financial, Inc. to Participate in 2026 KBW Insurance Conference; Live Webcast Available (Business Wire)
Aug-12-26 06:00AM	Prudential Advisors welcomes Ameriprise advisor to NJ Wealth Partners (PR Newswire)
Aug-11-26 04:18PM	Prudential Financial Declares Quarterly Dividend on Common Stock (Business Wire)
Aug-05-26 07:01PM	Prudential Financial Inc (PRU) (Q2 2026) Earnings Call Highlights: Record Group Insurance ... (GuruFocus.com)
08:30AM	Prudential Financial, Inc. Q2 2026 Earnings Call Summary (Moby)
Aug-04-26 04:18PM	Prudential Financial, Inc. Announces Second Quarter 2026 Results (Business Wire)
Aug-03-26 02:45PM	Kairoi Residential, PGIM, and Helaba Bank Have Broken Ground on their Ultra-Luxury Mid-Rise Development in Denver's Lower Highlands (LoHi) neighborhood. (PR Newswire)
Jul-27-26 08:55PM	What Should You Do With DVY At A New High? (Trefis)
06:15AM	Loading…
06:15AM	PGIM to Acquire Remaining Interest in Deerpath Capital (Business Wire)
Jul-09-26 04:45PM	Retirement inflation fears vs. reality: Why it's actually not as scary as it seems (Yahoo Finance Video)
01:35PM	Retirees worry inflation will ravage their savings, but the reality is often less scary (Yahoo Finance)
08:18AM	Prudential Financial, Inc. to Announce Second Quarter 2026 Earnings; Schedules Earnings and Strategy Call (Business Wire)
Jul-01-26 09:00AM	PGIM Introduces Quarterly Outcome Periods to Growing Buffer ETF Lineup (Business Wire)
Jun-25-26 06:00AM	Prudential Advisors Welcomes J.P. Morgan Advisor to Mid America Financial Group (PR Newswire)
Jun-22-26 09:00AM	Employers Embrace AI for Benefits - Employees Remain Cautious (Business Wire)
Jun-15-26 06:45AM	PGIM Announces Strategic Enhancements to Equity ETF Platform (Business Wire)
Jun-11-26 09:00AM	PGIM Launches Two New Securitized Credit ETFs, Including a AAA-Rated CLO ETF With Core-Like Duration Exposure (Business Wire)
Jun-09-26 09:32AM	Toll Brothers upgraded, Lennar downgraded: Wall Street's top analyst calls (The Fly)
Jun-02-26 09:32PM	PGIM Announces Net Asset Value Restatement for Three Exchange-Traded Funds (PAB, PSDM, PTRB) (Business Wire)
09:00AM	Prudential Retirement Expands Retail Distribution Through Independent Marketing Organizations, Launches New 'Elevate' Product Suite (Business Wire)
May-30-26 02:00AM	Inflation Squeezes Retirement. 5 Smart Tips to Protect Yourself. (Barrons.com)
May-29-26 04:18PM	PGIM Closed-End Funds Declare Distributions for June, July and August 2026 (Business Wire)
May-28-26 06:01AM	Quarterra and PGIM Celebrate Groundbreaking at Alexandria Crossing Apartments (PR Newswire)
01:21PM	Loading…
May-22-26 01:21PM	Prudential Buys 75% of Bharti Life in $365 Million India Expansion (GuruFocus.com)
May-21-26 08:00AM	PGIM Expands Active ETF Lineup with Launch of PGIM Jennison US Core Equity ETF (Business Wire)
May-20-26 09:00AM	PGIM Real Estate Fund completes 10th property acquisition, marking $260M in capital deployed (Business Wire)
08:35AM	Prismic Life Announces Completion of Oversubscribed Capital Raise (Business Wire)
May-14-26 02:31PM	PGIM Launches Its First Private Credit CIT for DC Plans (Wealth Management)
09:05AM	PGIM launches first private credit CIT to broaden defined contribution market access (Business Wire)
07:21AM	Employers say theyre doing enough to help with medical costs, but workers disagree (HR Dive)
May-12-26 04:18PM	Prudential Financial Declares Quarterly Dividend on Common Stock (Business Wire)
May-11-26 09:15AM	Employees Face Difficult Trade-offs Amid Rising Costs (Business Wire)
May-06-26 08:30AM	Prudential Financial, Inc. Q1 2026 Earnings Call Summary (Moby)
05:14AM	Prudential Financial Q1 2026 profit falls 15.6% after Japanese sales suspension (Life Insurance International)
May-05-26 04:18PM	Prudential Financial, Inc. Announces First Quarter 2026 Results (Business Wire)
May-04-26 11:19AM	Prudential Downgraded Again. Stock Faces 'Continued Valuation Pressure' From Japan Probe. (Barrons.com)
09:43AM	AMD downgraded, Airbnb upgraded: Wall Street's top analyst calls (The Fly)
Apr-23-26 09:00AM	PGIM Appoints Brian Towers to Lead Global Insurance and Strategic Partnerships (Business Wire)
05:45AM	Prudential hits pause on new sales at Japanese subsidiary (CFO.com)
Apr-22-26 12:20PM	Prudential Stock Slumps. A Misconduct Probe in Japan Is Getting 'Ugly.' (Barrons.com)
06:54AM	Stock Markets Must Play a Waiting Game Amid Iran and Fed Standoffs (Barrons.com)
Apr-21-26 04:43PM	Prudential Financial Stock Is Falling on Report of Potential Misconduct at Japan Insurer (Barrons.com) -5.99%
04:05PM	Prudential of Japan Extends Voluntary Sales Suspension by an Additional 180 Days (Business Wire)
Apr-18-26 03:02AM	How volatile are European stocks at Q1 reporting season? (Investing.com)
Apr-15-26 07:00AM	New Research Points to Lifetime Income as the Missing Link to Global Retirement Security (Business Wire)
Apr-13-26 04:18PM	Prudential Financial Recommends Shareholders Reject Unsolicited Mini-Tender Offer from Potemkin Limited (Business Wire)
Apr-08-26 08:35AM	Prudential Financial, Inc. to Announce First Quarter 2026 Earnings; Schedules Conference Call (Business Wire)
Apr-07-26 06:00AM	Prudential Advisors welcomes two advisors with over $300M in assets (PR Newswire)
Apr-02-26 12:02AM	The New Magic Retirement Number Is $1.46M (The Daily Upside)
Mar-31-26 08:00AM	PGIM Appoints Robert Sockin as US Economist (Business Wire)
Mar-26-26 01:30AM	22 S&P 500 Stocks Yield More Than 5%. 6 That Are Worth Buying. (Barrons.com)
Mar-24-26 06:00AM	Prudential Advisors' Moira Buckley elected Finseca secretary, set to serve as president in 2028-29 (PR Newswire)
Mar-12-26 09:30AM	Five PGIM Funds Recognized by 2026 LSEG Lipper Fund Awards (Business Wire)
Mar-11-26 05:05AM	Prudential price target lowered to $119 from $124 at Barclays (TipRanks)
Mar-10-26 04:18PM	Prudential Financial Board of Directors Appoints Chief Executive Officer Andrew Sullivan as Chairman (Business Wire)
01:24PM	These Dividend Stocks Pay More Than 10-Year Treasury Bonds (24/7 Wall St.)
Mar-09-26 10:14AM	How Is Prudential Financial's Stock Performance Compared to Other Insurance Stocks? (Barchart)
05:11AM	Prudentials Japan unit finds unauthorised data sharing by staff (Life Insurance International)
Mar-06-26 11:45AM	Prudential (PRU) Could Be a Great Choice (Zacks)
Mar-05-26 09:36PM	Morgan Stanley Reduces Prudential Financial (PRU) Price Target after Updating Insurance Estimates (Insider Monkey)
11:30AM	Why Is Prudential (PRU) Down 3.3% Since Last Earnings Report? (Zacks)
Mar-04-26 03:22PM	Is the Options Market Predicting a Spike in PRU Stock? (Zacks)
12:48AM	Wells Fargo Downgrades Prudential Financial, Inc. (PRU) to Underweight and Lowers its Price Target to $103 (Insider Monkey)
Mar-02-26 10:12AM	Dividend Investing Hasnt Been This Exciting In Some Time: 3 Stocks to Buy Immediately (24/7 Wall St.)
09:00AM	Prudential launches its ActiveIncome insurance overlay on Franklin Templetons Canvas platform for wealth managers (Business Wire)
Feb-27-26 04:18PM	PGIM Closed-End Funds declare distributions for March, April and May 2026 (Business Wire)
Feb-18-26 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
Feb-17-26 09:43AM	Prudential Financial Lags Industry, Trades at a Discount: Time to Hold? (Zacks)
06:00AM	Marivic Dar honored as a Luminaries with Heart recipient at the ThinkAdvisor 2025 Luminaries Awards (PR Newswire)
03:27AM	Prudential Financial Stock: Is Wall Street Bullish or Bearish? (Barchart)
Feb-11-26 07:30AM	Montana Capital Partners announces final close of MCP Opportunity Secondary Program VI (OSP VI) (Business Wire)
Feb-10-26 08:35AM	Prudential Financial Elects Maryann Mannen to Board of Directors (Business Wire)
12:35AM	The Top 5 Analyst Questions From Prudential's Q4 Earnings Call (StockStory)
Feb-06-26 02:39PM	AM Best Affirms Credit Ratings of Prudential Financial, Inc. and Its Life/Health Subsidiaries (Business Wire)
Feb-05-26 07:44AM	MKL Q4 Earnings Beat Estimates, Revenues & Premiums Rise Y/Y (Zacks)
04:06AM	Prudential Financial Q4 Earnings Call Highlights (MarketBeat)
03:46AM	Company News for Feb 5, 2026 (Zacks)
Feb-04-26 06:01PM	Prudential Financial Inc (PRU) Q4 2025 Earnings Call Highlights: Strong Financial Performance ... (GuruFocus.com)
02:50PM	PRU Q4 Deep Dive: Japan Sales Suspension and Asset Management Outflows Shape Outlook (StockStory)
09:40AM	Why Prudential (PRU) is a Top Value Stock for the Long-Term (Zacks)
09:13AM	Prudential Financial Q4 Earnings Miss, Revenues Beat, Dividend Raised (Zacks)
Feb-03-26 07:00PM	Prudential (PRU) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:35PM	Prudential (PRU) Lags Q4 Earnings Estimates (Zacks)
05:28PM	Prudential (NYSE:PRU) Reports Q4 CY2025 In Line With Expectations (StockStory)
04:42PM	Prudential: Q4 Earnings Snapshot (Associated Press Finance)
04:18PM	Prudential Financial, Inc. Announces Full Year and Fourth Quarter 2025 Results (Business Wire)
04:13PM	Prudential of Japan Implements Voluntary 90-Day Suspension of New Sales to Address Previously Disclosed Employee Misconduct (Business Wire)
Feb-02-26 10:11AM	Watch These 5 Insurance Stocks for Q4 Earnings: Beat or Miss? (Zacks)
06:52AM	Prudential Financial (PRU) Price Target Raised by $2, 'Hold' Rating Maintained (Insider Monkey)
Feb-01-26 10:04PM	What To Expect From Prudential's (PRU) Q4 Earnings (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-30-26 09:48AM	PRU Gears Up to Report Q4 Earnings: Here's What to Expect (Zacks)
05:34AM	Analyst Report: Prudential plc (Morningstar Research)

Prudential Financial, Inc. engages in the provision of insurance, investment management, and other financial products and services. It operates through the following segments: Prudential Investment Management, Inc. (PGIM), U.S. Businesses, International Businesses, and Corporate and Others. The PGIM segment is involved in the provision of investment management services and solutions related to public fixed income, public equity, real estate debt and equity, private credit and other alternatives, and multi-asset class strategies. The U.S. Businesses segment includes retirement strategies, group insurance, and individual life. The International Businesses segment focuses on investing in existing businesses and assessing acquisition opportunities. The Corporate and Other Operations segment relates to the corporate items and initiatives not allocated to business segments. The company was founded by John Fairfield Dryden in 1875 and is headquartered in Newark, NJ.

ChairmanMr. Andrew Francis Sullivan

Executive VP & CFOMs. Yanela del Carmen Frias

Executive VP & Head of Global Technology and OperationsMr. Scott E. Case

President & CEO of PGIM Inc.Mr. Jacques Philppe Chappuis

Senior VP & Chief Investment OfficerMr. Matthew J. Armas

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Boyle Robert E	Senior Vice President	Aug 31 '26	Option Exercise	0.00	353	0	6,087	Sep 02 01:50 PM
KAPPLER ANN M	EVP and General Counsel	Aug 14 '26	Sale	125.01	7,652	956,577	14,407	Aug 18 05:03 PM
KAPPLER ANN M	Officer	Aug 14 '26	Proposed Sale	125.00	7,652	956,500		Aug 14 06:05 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Jul 28 '26	Sale	24.75	214,746	5,314,972	7,973,657	Jul 30 03:31 PM
PRUDENTIAL FINANCIAL INC	10% Owner	Jul 15 '26	Buy	10.00	6,000,000	60,000,000	3,000,000	Jul 17 01:20 PM
KAPPLER ANN M	EVP and General Counsel	May 14 '26	Sale	103.25	13,580	1,402,135	22,059	May 18 03:16 PM
KAPPLER ANN M	Officer	May 14 '26	Proposed Sale	103.00	13,580	1,398,740		May 14 02:57 PM
POON CHRISTINE A	Director	May 12 '26	Option Exercise	0.00	1,765	0	13,348	May 14 12:47 PM
CASELLAS GILBERT F	Director	May 12 '26	Option Exercise	0.00	1,765	0	2,265	May 14 12:33 PM
Chappuis Jacques	Executive Vice President	Apr 30 '26	Option Exercise	0.00	10,333	0	7,922	May 04 02:52 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Apr 29 '26	Buy	30.36	270,092	8,200,000	3,573,699	May 01 02:58 PM
Walia Vicki	Executive Vice President	Feb 28 '26	Option Exercise	0.00	2,384	0	5,598	Mar 03 05:15 PM
Waldeck George P Jr.	Executive Vice President	Feb 28 '26	Option Exercise	0.00	5,588	0	70,383	Mar 03 05:12 PM
SULLIVAN ANDREW F	Chief Executive Officer	Feb 28 '26	Option Exercise	0.00	11,711	0	52,014	Mar 03 05:07 PM
SCHMIDT TIMOTHY L	Senior Vice President	Feb 28 '26	Option Exercise	0.00	4,779	0	21,033	Mar 03 05:04 PM
Lowrey Charles F	Chairman of the Board	Feb 28 '26	Option Exercise	0.00	31,985	0	224,787	Mar 03 05:01 PM
KAPPLER ANN M	EVP and General Counsel	Feb 28 '26	Option Exercise	0.00	7,071	0	36,737	Mar 03 04:54 PM
Frias Yanela	EVP and CFO	Feb 28 '26	Option Exercise	0.00	4,007	0	23,638	Mar 03 04:48 PM
Case Scott	Executive Vice President	Feb 28 '26	Option Exercise	0.00	2,717	0	2,717	Mar 03 04:45 PM
Stoddard Thomas D	Director	Feb 17 '26	Buy	102.97	250	25,742	250	Feb 18 10:03 AM
Wolk Joseph J	Director	Feb 11 '26	Buy	105.32	400	42,128	400	Feb 12 09:44 AM
Walia Vicki	Executive Vice President	Feb 09 '26	Option Exercise	0.00	770	0	3,931	Feb 11 04:51 PM
Waldeck George P Jr.	Executive Vice President	Feb 09 '26	Option Exercise	0.00	10,924	0	69,836	Feb 11 04:48 PM
SULLIVAN ANDREW F	Chief Executive Officer	Feb 09 '26	Option Exercise	0.00	32,065	0	59,137	Feb 11 04:46 PM
SCHMIDT TIMOTHY L	Senior Vice President	Feb 09 '26	Option Exercise	0.00	10,176	0	21,611	Feb 11 04:43 PM
Lowrey Charles F	Chairman of the Board	Feb 09 '26	Option Exercise	0.00	83,367	0	248,931	Feb 11 04:41 PM
KAPPLER ANN M	EVP and General Counsel	Feb 09 '26	Option Exercise	0.00	17,636	0	39,142	Feb 11 04:38 PM
Frias Yanela	EVP and CFO	Feb 09 '26	Option Exercise	0.00	4,190	0	21,756	Feb 11 04:35 PM
Feeney Caroline	Executive Vice President	Feb 09 '26	Option Exercise	0.00	23,728	0	77,247	Feb 11 04:30 PM
Boyle Robert E	Senior Vice President	Feb 09 '26	Option Exercise	0.00	1,020	0	3,830	Feb 11 04:14 PM
Chappuis Jacques	Executive Vice President	Feb 06 '26	Buy	100.97	1,000	100,970	1,000	Feb 09 04:51 PM
Walia Vicki	Executive Vice President	Jan 31 '26	Option Exercise	0.00	5,033	0	5,033	Feb 03 05:44 PM
PRUDENTIAL INSURANCE CO OF AME	10% Owner	Jan 23 '26	Buy	24.87	1,406,739	34,985,590	7,709,624	Jan 27 04:30 PM
Feeney Caroline	Executive Vice President	Jan 12 '26	Option Exercise	0.00	60,761	0	83,378	Jan 14 10:48 AM
Feeney Caroline	Executive Vice President	Dec 11 '25	Option Exercise	107.67	6,662	717,284	25,449	Dec 15 05:49 PM
Feeney Caroline	Executive Vice President	Dec 11 '25	Sale	116.28	6,555	762,215	22,523	Dec 15 05:49 PM
Feeney Caroline	Officer	Dec 11 '25	Proposed Sale	116.28	6,662	774,657		Dec 11 03:04 PM
SCHMIDT TIMOTHY L	Senior Vice President	Dec 02 '25	Sale	107.69	8,000	861,520	11,535	Dec 02 04:45 PM
SCHMIDT TIMOTHY L	Officer	Dec 02 '25	Proposed Sale	107.69	8,000	861,520		Dec 02 02:56 PM
Lowrey Charles F	Chairman of the Board	Nov 10 '25	Sale	107.39	48,164	5,172,332	165,564	Nov 12 05:00 PM
Lowrey Charles F	Officer	Nov 10 '25	Proposed Sale	106.00	48,164	5,105,384		Nov 10 06:33 PM

JNJ

Johnson & Johnson

PRU

Prudential Financial Inc

Upgrade your Finviz experience